| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 39.2K | May 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OACC | Oaktree Acquisition Corp. III Life Sciences | Oct 23, 2024 | 0 | $0 | 3 | Oct 23, 2024 | Director |
| ZVRA | ZEVRA THERAPEUTICS, INC. | May 13, 2024 | 1 | $0 | 4 | May 15, 2024 | Director |
| ZVRA | ZEVRA THERAPEUTICS, INC. | Jan 20, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Director |
| ZVRA | ZEVRA THERAPEUTICS, INC. | Jan 20, 2024 | 0 | $0 | 3 | Feb 2, 2024 | Director |